Insomnia - Global Market Outlook (2017-2023)

  • ID: 4426460
  • Report
  • Region: Global
  • 198 pages
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Astellas
  • Biocodex S A
  • Consumer Healthcare Inc.
  • Dainippon Sumitomo
  • ECR Pharmaceuticals
  • Eisai Co.
  • MORE

Working in rational shifts & stressful work conditions, recent technological advancements and increasing demand for OTC sleep aids are some of the factors favoring the market growth. In addition, presence of large undiagnosed insomnia population pool and untapped markets in developing economies are the key opportunities for the market growth. On the contrary, side effects of benzodiazepine and non-benzodiazepine drugs, expiration of patients and increase in non pharmacological therapies are hindering the market growth.

Insomnia is a sleep disorder where in the person faces difficultly to sleep or remain asleep. The indications include depression, irritability, low stamina and daytime sleepiness. It is a highly predominant disorder that affects millions of people, globally. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical conditions. Furthermore, usage of drugs, such as alcohol, nicotine and caffeine will lead to insomnia.

In 2016, North America accounted for the highest market share in the insomnia market and is expected to maintain its dominance throughout the forecast period. In the U.S., the OTC treatment market is expected to hold a greater CAGR to address its growth in the insomnia pharmacological treatment. It is predicted to earn backing from the increasing utilization of melatonin valerian and roots, outstanding to their crucial advantages such as reduced stress levels and low side effects. Asia Pacific als-appeared as a proper opportunity to capitalize on with the lifting disposable income and upsurge in the occurrence of chronic diseases.

Some of the key players in global insomnia market include Astellas, Biocodex S A, Consumer Healthcare Inc., Dainippon Sumitomo, ECR Pharmaceuticals, Eisai Co., Flynn Pharma, Johnson & Johnson, Meda Consumer Healthcare Inc., Merck & Co. Inc., Neurim, Pernix, Therapeutics, Pfizer Inc, Purdue Pharma L.P., Sanofi Pasteur, SkyePharma and Takeda Pharmaceutical Company.

Therapy Type Covered:

  • Pharmacological Therapy
  • Non-pharmacological Therapy

Disorder Durations Covered:

  • Chronic Insomnia
  • Transient Insomnia
  • Acute Insomnia

Disorder Conditions Covered:

  • Sleep onset and/or Maintenance
  • Poor Quality of Sleep
  • Other Disorder Condition

Formulation Types Covered:

  • Capsules
  • Tablets
  • Oral mists

Regions Covered:

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
  • South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What The Report Offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astellas
  • Biocodex S A
  • Consumer Healthcare Inc.
  • Dainippon Sumitomo
  • ECR Pharmaceuticals
  • Eisai Co.
  • MORE
1. Executive Summary

2. Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3. Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario

4. Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5. Global Insomnia Market, By Therapy Type
5.1 Introduction
5.2 Pharmacological Therapy
5.2.1 Over-the-Counter sleep aids
5.2.1.1 Melatonin
5.2.1.2 Antihistamines
5.2.1.3 Valerian roots
5.2.1.4 Other Herbal and dietary supplements
5.2.2 Prescription sleep aids
5.2.2.1 Benzodiazepines
5.2.2.2 Orexin Antagonists
5.2.2.3 Melatonin Receptor Agonists
5.2.2.4 Non-benzodiazepines
5.2.2.4.1 Eszopiclone
5.2.2.4.2 Zolpidem
5.2.2.4.3 Zaleplon
5.2.2.5 Other prescription sleep aids
5.2.2.5.1 Tricyclic Antidepressants.
5.2.2.5.2 Antipsychotics
5.2.2.5.3 Chloral Derivatives
5.3 Non-pharmacological Therapy
5.3.1 Medical Devices
5.3.2 Cognitive Behavioral Therapy
5.3.3 Hypnotherapy
5.3.4 Paradoxical intention
5.3.5 Sleep hygiene education
5.3.6 Stimulus control
5.3.7 Other Alternative Therapies
5.3.7.1 Acupuncture
5.3.7.2 Bright light therapy
5.3.7.3 Aroma therapy
5.3.7.4 Music therapy
5.3.7.5 Exercise/Yoga
5.3.7.6 Biofeedback

6. Global Insomnia Market, By Disorder Duration
6.1 Introduction
6.2 Chronic Insomnia
6.3 Transient Insomnia
6.4 Acute Insomnia

7. Global Insomnia Market, By Disorder Condition
7.1 Introduction
7.2 Sleep onset and/or Maintenance
7.3 Poor Quality of Sleep
7.4 Other Disorder Condition

8. Global Insomnia Market, By Formulation Type
8.1 Introduction
8.2 Capsules
8.3 Tablets
8.3.1 Sublingual Tablets
8.3.2 Film-Coated Tablets
8.4 Oral mists

9. Global Insomnia Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10. Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11. Company Profiling
11.1 Astellas
11.2 Biocodex S A
11.3 Consumer Healthcare Inc.
11.4 Dainippon Sumitomo
11.5 ECR Pharmaceuticals
11.6 Eisai Co.
11.7 Flynn Pharma
11.8 Johnson & Johnson
11.9 Meda Consumer Healthcare Inc.
11.10 Merck & Co. Inc.
11.11 Neurim
11.12 Pernix Therapeutics
11.13 Pfizer Inc
11.14 Purdue Pharma L.P.
11.15 Sanofi Pasteur
11.16 SkyePharma
11.17 Takeda Pharmaceutical Company

List of Tables

Table 1 Global Insomnia Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
Table 3 Global Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
Table 4 Global Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
Table 5 Global Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
Table 6 Global Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
Table 7 Global Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
Table 8 Global Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
Table 9 Global Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
Table 10 Global Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
Table 11 Global Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
Table 12 Global Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
Table 13 Global Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
Table 14 Global Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
Table 15 Global Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
Table 16 Global Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
Table 17 Global Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
Table 18 Global Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
Table 19 Global Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
Table 20 Global Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
Table 21 Global Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
Table 22 Global Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
Table 23 Global Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
Table 24 Global Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
Table 25 Global Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
Table 26 Global Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
Table 27 Global Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Table 28 North America Insomnia Market Outlook, By Country (2014-2023) ($MN)
Table 29 North America Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
Table 30 North America Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
Table 31 North America Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
Table 32 North America Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
Table 33 North America Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
Table 34 North America Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
Table 35 North America Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
Table 36 North America Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
Table 37 North America Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
Table 38 North America Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
Table 39 North America Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
Table 40 North America Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
Table 41 North America Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
Table 42 North America Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
Table 43 North America Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
Table 44 North America Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
Table 45 North America Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
Table 46 North America Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
Table 47 North America Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
Table 48 North America Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
Table 49 North America Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
Table 50 North America Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
Table 51 North America Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
Table 52 North America Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
Table 53 North America Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
Table 54 North America Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Table 55 Europe Insomnia Market Outlook, By Country (2014-2023) ($MN)
Table 56 Europe Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
Table 57 Europe Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
Table 58 Europe Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
Table 59 Europe Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
Table 60 Europe Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
Table 61 Europe Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
Table 62 Europe Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
Table 63 Europe Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
Table 64 Europe Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
Table 65 Europe Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
Table 66 Europe Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
Table 67 Europe Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
Table 68 Europe Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
Table 69 Europe Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
Table 70 Europe Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
Table 71 Europe Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
Table 72 Europe Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
Table 73 Europe Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
Table 74 Europe Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
Table 75 Europe Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
Table 76 Europe Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
Table 77 Europe Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
Table 78 Europe Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
Table 79 Europe Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
Table 80 Europe Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
Table 81 Europe Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Table 82 Asia pacific Insomnia Market Outlook, By Country (2014-2023) ($MN)
Table 83 Asia pacific Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
Table 84 Asia pacific Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
Table 85 Asia pacific Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
Table 86 Asia pacific Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
Table 87 Asia pacific Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
Table 88 Asia pacific Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
Table 89 Asia pacific Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
Table 90 Asia pacific Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
Table 91 Asia pacific Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
Table 92 Asia pacific Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
Table 93 Asia pacific Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
Table 94 Asia pacific Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
Table 95 Asia pacific Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
Table 96 Asia pacific Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
Table 97 Asia pacific Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
Table 98 Asia pacific Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
Table 99 Asia pacific Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
Table 100 Asia pacific Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
Table 101 Asia pacific Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
Table 102 Asia pacific Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
Table 103 Asia pacific Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
Table 104 Asia pacific Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
Table 105 Asia pacific Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
Table 106 Asia pacific Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
Table 107 Asia pacific Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
Table 108 Asia pacific Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Table 109 South America Insomnia Market Outlook, By Country (2014-2023) ($MN)
Table 110 South America Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
Table 111 South America Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
Table 112 South America Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
Table 113 South America Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
Table 114 South America Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
Table 115 South America Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
Table 116 South America Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
Table 117 South America Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
Table 118 South America Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
Table 119 South America Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
Table 120 South America Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
Table 121 South America Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
Table 122 South America Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
Table 123 South America Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
Table 124 South America Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
Table 125 South America Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
Table 126 South America Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
Table 127 South America Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
Table 128 South America Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
Table 129 South America Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
Table 130 South America Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
Table 131 South America Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
Table 132 South America Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
Table 133 South America Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
Table 134 South America Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
Table 135 South America Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Table 136 Middle East & Africa Insomnia Market Outlook, By Country (2014-2023) ($MN)
Table 137 Middle East & Africa Insomnia Market Outlook, By Therapy Type (2014-2023) ($MN)
Table 138 Middle East & Africa Insomnia Market Outlook, By Pharmacological Therapy (2014-2023) ($MN)
Table 139 Middle East & Africa Insomnia Market Outlook, By Over-the-Counter sleep aids (2014-2023) ($MN)
Table 140 Middle East & Africa Insomnia Market Outlook, By Prescription sleep aids (2014-2023) ($MN)
Table 141 Middle East & Africa Insomnia Market Outlook, By Non-pharmacological Therapy (2014-2023) ($MN)
Table 142 Middle East & Africa Insomnia Market Outlook, By Medical Devices (2014-2023) ($MN)
Table 143 Middle East & Africa Insomnia Market Outlook, By Cognitive Behavioral Therapy (2014-2023) ($MN)
Table 144 Middle East & Africa Insomnia Market Outlook, By Hypnotherapy (2014-2023) ($MN)
Table 145 Middle East & Africa Insomnia Market Outlook, By Paradoxical intention (2014-2023) ($MN)
Table 146 Middle East & Africa Insomnia Market Outlook, By Sleep hygiene education (2014-2023) ($MN)
Table 147 Middle East & Africa Insomnia Market Outlook, By Stimulus control (2014-2023) ($MN)
Table 148 Middle East & Africa Insomnia Market Outlook, By Other Alternative Therapies (2014-2023) ($MN)
Table 149 Middle East & Africa Insomnia Market Outlook, By Disorder Duration (2014-2023) ($MN)
Table 150 Middle East & Africa Insomnia Market Outlook, By Chronic Insomnia (2014-2023) ($MN)
Table 151 Middle East & Africa Insomnia Market Outlook, By Transient Insomnia (2014-2023) ($MN)
Table 152 Middle East & Africa Insomnia Market Outlook, By Acute Insomnia (2014-2023) ($MN)
Table 153 Middle East & Africa Insomnia Market Outlook, By Disorder Condition (2014-2023) ($MN)
Table 154 Middle East & Africa Insomnia Market Outlook, By Sleep onset and/or Maintenance (2014-2023) ($MN)
Table 155 Middle East & Africa Insomnia Market Outlook, By Poor Quality of Sleep (2014-2023) ($MN)
Table 156 Middle East & Africa Insomnia Market Outlook, By Other Disorder Condition (2014-2023) ($MN)
Table 157 Middle East & Africa Insomnia Market Outlook, By Formulation Type (2014-2023) ($MN)
Table 158 Middle East & Africa Insomnia Market Outlook, By Capsules (2014-2023) ($MN)
Table 159 Middle East & Africa Insomnia Market Outlook, By Tablets (2014-2023) ($MN)
Table 160 Middle East & Africa Insomnia Market Outlook, By Sublingual Tablets (2014-2023) ($MN)
Table 161 Middle East & Africa Insomnia Market Outlook, By Film-Coated Tablets (2014-2023) ($MN)
Table 162 Middle East & Africa Insomnia Market Outlook, By Oral mists (2014-2023) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Astellas
  • Biocodex S A
  • Consumer Healthcare Inc.
  • Dainippon Sumitomo
  • ECR Pharmaceuticals
  • Eisai Co.
  • Flynn Pharma
  • Johnson & Johnson
  • Meda Consumer Healthcare Inc.
  • Merck & Co. Inc.
  • Neurim
  • Pernix Therapeutic
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll